Alfonso Gúrpide

Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma

Kurt A. Schalper, María E. Rodríguez-Ruiz, Ricardo Díez-Valle et al. · Nature Medicine · 2019 · 642 citations

Neuro-oncology, Cancer Immunosurveillance, Medicine +11

Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients

Miguel F. Sanmamed, José Luis Perez‐Gracia, Kurt A. Schalper et al. · Annals of Oncology · 2017 · 442 citations · Full text

Cancer Immunosurveillance, Anti-pd-1 Treatment, Medicine +8

Brain metastases from lung cancer responding to erlotinib: the importance of<i>EGFR</i>mutation

R. Porta, J.M. Sánchez-Torres, Luis Paz‐Ares et al. · European Respiratory Journal · 2010 · 316 citations · Full text

Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes

Carlos Alfaro, Natalia Suárez, Álvaro González et al. · British Journal of Cancer · 2009 · 208 citations · Full text

Phase II Proof-of-Concept Study of Pazopanib Monotherapy in Treatment-Naive Patients With Stage I/II Resectable Non–Small-Cell Lung Cancer

Nasser K. Altorki, Maureen E. Lane, Thomas Bauer et al. · Journal of Clinical Oncology · 2010 · 139 citations · Full text